On July 20, 2015, Imexpharm welcomed a delegation of 31 representatives from 18 investment funds and securities companies, alongside Đầu Tư Chứng Khoán Newspaper, for an exclusive tour of its two upgrading factories: the Cephalosporin and Penicillin Injection plants at VSIP II Industrial Park in Binh Duong.

This visit, organized at the request of FPTS Securities, showcased Imexpharm's commitment to elevating its production capabilities. Just a week later, on July 29, 2015, the company hosted 15 representatives from 11 investment funds and securities firms at its headquarters and factory in Cao Lanh City, Dong Thap, following an invitation by Ban Viet Capital Securities. Imexpharm's ongoing upgrades to meet EU-GMP standards, coupled with its promising operational potential and forward-looking strategies, have attracted considerable attention from both domestic and international investors.

Mr. Nguyen Quoc Dinh, Chairman of the Board of Directors of Imexpharm, personally met with the investors, introduced the company, and addressed all their questions. The discussions revolved around key topics of high interest to investors, including: Potential and development strategies for the OTC and ETC markets in the coming years; Current operational capacity of the factories; Timelines for completing the factory upgrades and obtaining EU-GMP certification; New regulations in the amended bidding law; Advantages of domestically produced EU-GMP-certified drugs in tenders; Comparisons of production costs under EU-GMP and WHO-GMP standards; Strategic direction for Imexpharm's high-tech factory; Partnerships with Pha No; R&D investment levels, and more.

Investors expressed high appreciation for the modern facilities of Imexpharm’s factories, its operational advantages, and its growth potential. They also showed particular interest in Imexpharm's sustainable development strategies and its 2014 Sustainability Report.

At Imexpharm, we are honored to host and engage with investors and shareholders. We are committed to transparency as a core value and strive to provide added value to all stakeholders involved.